If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 326.50
Bid: 325.00
Ask: 326.00
Change: 3.50 (1.08%)
Spread: 1.00 (0.308%)
Open: 328.50
High: 329.50
Low: 322.50
Prev. Close: 323.00
MGAM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Capital Markets Event

6 Dec 2022 07:00

RNS Number : 6717I
Morgan Advanced Materials PLC
06 December 2022
 

Press Release

Morgan Advanced Materials plc

6 December 2022

 

Capital Markets Event

"Delivering resilient, scalable growth"

Morgan Advanced Materials plc will hold a Capital Markets Event this afternoon at the Science Museum in London.

The event will include a series of presentations by our senior leadership team, which will focus on our opportunities for profitable growth as a global manufacturer of advanced carbon and ceramic materials for complex and technologically demanding applications. These include specific initiatives to drive sustainable growth through the industrial cycle.

We also set out the following through the cycle financial objectives:

- Accelerating Organic Revenue Growth. Extending our position in faster growing markets, supporting 3-6% p.a.

- Attractive Margins. 12.5% - 15% adjusted operating profit margin

- Delivering EPS Growth.  Achieving enhanced growth in adjusted Earnings per Share, ahead of organic revenue growth, driven by a combination of organic growth, inorganic activity and shareholder returns

- Leverage Range. 1.0x to 2.0x adjusted EBITDA

- Sustaining ROIC. 17 - 20% ROIC

In addition, we set out the following capital allocation policies:

- Focussing Organic Investment.  Investment to enhance growth and returns, including an additional £60m of capital in our Semiconductor manufacturing capacity over the next few years

- Enhancing Regular Returns via a Progressive Dividend Policy. Grow the regular dividend through the cycle with an adjusted earnings cover of c.2.5x

- Inorganic Activity. Complementary, disciplined M&A focused on accelerating revenue growth opportunities in faster growing markets

- Additional Returns. Additional returns of surplus capital to shareholders as appropriate.

The presentation for the event will be made available at www.morganadvancedmaterials.com at 14:00 UK time today. A recording of the presentation will be made available following the event.

Accelerated Pension Contribution

We have agreed with the Trustees of our UK Defined Benefit Pension Schemes a contribution of £67m that will create further balance sheet flexibility whilst substantially reducing future cash contributions. Further detail is provided in a separate RNS released today.

RCF Renewal

We have secured a new five-year Revolving Credit Facility of £230m that replaces our existing RCF that was due to mature in 2023.

FY22 Guidance

Our outlook and guidance for full year 2022 provided in our Trading Update of 4 November 2022 remain unchanged.

 

For further enquiries:

Pete Raby, CEO

Morgan Advanced Materials plc

01753 837000

Richard Armitage, CFO

Nina Coad

Brunswick

0207 404 5959

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUVSWRUBUURAA
Date   Source Headline
22nd Aug 20132:33 pmRNSDirector/PDMR Shareholding
20th Aug 20132:51 pmRNSDirector/PDMR Shareholding
13th Aug 20135:35 pmRNSHolding(s) in Company
8th Aug 20134:14 pmRNSDirector/PDMR Shareholding
8th Aug 20139:35 amRNSHalf Yearly Report
5th Aug 20131:01 pmRNSDirector/PDMR Shareholding
30th Jul 201310:45 amRNSDirector/PDMR Shareholding
24th Jul 20137:00 amRNSHalf Year Results
27th Jun 201310:12 amRNSHolding(s) in Company
24th Jun 201310:36 amRNSBlocklisting Interim Review
7th Jun 20131:40 pmRNSDirector/PDMR Shareholding
5th Jun 20134:43 pmRNSDirector/PDMR Shareholding
4th Jun 201310:52 amRNSHolding(s) in Company
31st May 201310:40 amRNSTotal Voting Rights
31st May 201310:24 amRNSDirector/PDMR Shareholding
28th May 20135:19 pmRNSDirector/PDMR Shareholding
24th May 201312:18 pmRNSIssue of Equity
24th May 201310:12 amRNSNon Regulatory Announcement
22nd May 20134:25 pmRNSDirector/PDMR Shareholding
20th May 201311:39 amRNSDirector/PDMR Shareholding
17th May 201312:57 pmRNSDirector/PDMR Shareholding
10th May 20134:55 pmRNSResult of AGM
10th May 201310:00 amRNSAppointment of a Non-Executive Director
10th May 20137:00 amRNSInterim Management Statement
24th Apr 201312:09 pmRNSScrip Dividend Price
19th Apr 201311:20 amRNSDirector/PDMR Shareholding
10th Apr 201310:14 amRNSDirector/PDMR Shareholding
27th Mar 20135:38 pmRNSChange of Name
26th Mar 20134:25 pmRNSAnnual Financial Report
26th Mar 201311:44 amRNSDirector/PDMR Shareholding
14th Mar 20139:54 amRNSDirector/PDMR Shareholding
12th Mar 20131:50 pmRNSDirector/PDMR Shareholding
26th Feb 20133:55 pmRNSHolding(s) in Company
19th Feb 20131:09 pmRNSHolding(s) in Company
19th Feb 20131:08 pmRNSHolding(s) in Company
14th Feb 20137:05 amRNSChange of responsibilities of a director
14th Feb 20137:00 amRNSFull Year Results
5th Feb 20135:40 pmRNSHolding(s) in Company
31st Jan 201310:44 amRNSTotal Voting Rights
18th Jan 201312:38 pmRNSHolding(s) in Company
15th Jan 20132:07 pmRNSDirector/PDMR Shareholding
10th Jan 20139:54 amRNSTotal Voting Rights
3rd Jan 20133:47 pmRNSIssue of Equity
18th Dec 20124:54 pmRNSBlocklisting Interim Review
11th Dec 20129:35 amRNSDirector/PDMR Shareholding
6th Dec 20129:59 amRNSDirector/PDMR Shareholding
6th Dec 20129:55 amRNSDirector/PDMR Shareholding
29th Nov 20129:07 amRNSScrip Dividend Price
30th Oct 20125:08 pmRNSHolding(s) in Company
30th Oct 20129:15 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.